Zheng Y, Shen Q, Yang F, Wang J, Zhou Q, Hu R
Front Oncol. 2024; 14:1442489.
PMID: 39588304
PMC: 11586258.
DOI: 10.3389/fonc.2024.1442489.
Jiang J, Zhu J, Qiu P, Ni J, Zhu W, Wang X
Funct Integr Genomics. 2023; 24(1):3.
PMID: 38091112
DOI: 10.1007/s10142-023-01279-7.
Das A, Mathur S, Kumar S, Bhatla N
Sultan Qaboos Univ Med J. 2023; 23(3):303-310.
PMID: 37655078
PMC: 10467544.
DOI: 10.18295/squmj.12.2022.066.
Torricelli F, Sauta E, Manicardi V, Mandato V, Palicelli A, Ciarrocchi A
Cells. 2023; 12(5).
PMID: 36899930
PMC: 10001006.
DOI: 10.3390/cells12050794.
Mitra S, Lami M, Ghosh A, Das R, Tallei T, Fatimawali
Cancers (Basel). 2022; 14(3).
PMID: 35159024
PMC: 8833573.
DOI: 10.3390/cancers14030759.
Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer.
Ran C, Sun J, Qu Y, Long N
World J Surg Oncol. 2021; 19(1):343.
PMID: 34886853
PMC: 8656033.
DOI: 10.1186/s12957-021-02448-3.
Incidence of Atrial Fibrillation in Postmenopausal Women with Endometrial Cancer.
Parahuleva M, Kreutz J, Euler G, Terzieva D, Mardini A, Uchikova E
J Clin Med. 2021; 10(2).
PMID: 33450923
PMC: 7828400.
DOI: 10.3390/jcm10020266.
PGC1α and VDAC1 expression in endometrial cancer.
Castro Wersall O, Lofstedt L, Govorov I, Mints M, Gabrielson M, Shoshan M
Mol Clin Oncol. 2021; 14(2):42.
PMID: 33437480
PMC: 7788556.
DOI: 10.3892/mco.2020.2203.
Effect of Pelvic Lymphadenectomy on Survival in Patients with Low-Risk Early-Stage Endometrial Cancer Diagnosed Intraoperatively Using Frozen Tissue Sections: A Retrospective Analysis.
Liu C, Zhao J, Liu S, Ma Y, Yang Y, Qu P
Cancer Manag Res. 2020; 12:10715-10723.
PMID: 33149678
PMC: 7605598.
DOI: 10.2147/CMAR.S274992.
Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.
Besso M, Montivero L, Lacunza E, Argibay M, Abba M, Furlong L
Oncol Rep. 2020; 44(3):873-886.
PMID: 32705231
PMC: 7388212.
DOI: 10.3892/or.2020.7648.
FOXM1 as a prognostic biomarker promotes endometrial cancer progression via transactivation of SLC27A2 expression.
Feng Y, Li S, Zhang R, Liu F, Xu Q, Ding H
Int J Clin Exp Pathol. 2020; 11(8):3846-3857.
PMID: 31949772
PMC: 6962789.
FXYD5/Dysadherin, a Biomarker of Endometrial Cancer Myometrial Invasion and Aggressiveness: Its Relationship With TGF-β1 and NF-κB Pathways.
Besso M, Rosso M, Lapyckyj L, Moiola C, Matos M, Mercogliano M
Front Oncol. 2019; 9:1306.
PMID: 31867269
PMC: 6908519.
DOI: 10.3389/fonc.2019.01306.
Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells.
Takeuchi M, Tanikawa M, Nagasaka K, Oda K, Kawata Y, Oki S
Cancers (Basel). 2019; 11(12).
PMID: 31805725
PMC: 6966633.
DOI: 10.3390/cancers11121913.
Interplay between miRNAs and Genes Associated with Cell Proliferation in Endometrial Cancer.
Hermyt E, Zmarzly N, Grabarek B, Kruszniewska-Rajs C, Gola J, Jeda-Golonka A
Int J Mol Sci. 2019; 20(23).
PMID: 31795319
PMC: 6928856.
DOI: 10.3390/ijms20236011.
Endometrial carcinoma complicated by malignant pericardial effusion: A case report on the therapeutic regimen.
Liu G, Zhang Q, Li Z, Chen X, Zhang N, Zhang J
Medicine (Baltimore). 2019; 98(42):e17584.
PMID: 31626128
PMC: 6824758.
DOI: 10.1097/MD.0000000000017584.
Validation of Molecular Typing for Endometrial Screening Test That Predicts Benign and Malignant Lesions.
Tuo X, Zhao L, Wang Q, Han L, Wang Y, Ma S
Front Oncol. 2019; 9:561.
PMID: 31338322
PMC: 6629861.
DOI: 10.3389/fonc.2019.00561.
Isolated Incisional Recurrence in a Patient with Early-Stage Endometrial Cancer: A Case Report and Review of the Literature.
Hirayama T, Kusunoki S, Fujino K, Terao Y, Itakura A
Gynecol Minim Invasive Ther. 2019; 8(2):73-75.
PMID: 31143627
PMC: 6515753.
DOI: 10.4103/GMIT.GMIT_81_18.
FAM98A promotes cancer progression in endometrial carcinoma.
Li Z, Li N, Sun X, Wang J
Mol Cell Biochem. 2019; 459(1-2):131-139.
PMID: 31114934
DOI: 10.1007/s11010-019-03556-1.
Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
Schlappe B, Weaver A, Ducie J, Zahl Eriksson A, Dowdy S, Cliby W
Gynecol Oncol. 2018; 151(2):235-242.
PMID: 30177461
PMC: 6214768.
DOI: 10.1016/j.ygyno.2018.08.022.
The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol.
Ryan N, Blake D, Cabrera-Dandy M, Glaire M, Evans D, Crosbie E
Syst Rev. 2018; 7(1):121.
PMID: 30115102
PMC: 6097297.
DOI: 10.1186/s13643-018-0792-8.
